Revolutionary tissue reconstruction tech secures €50M boost

TISSIUM, a cutting-edge medtech company specializing in biomorphic programmable polymers for tissue reconstruction, has successfully raised €50 million in a Series D funding round. The investment, supported by both new and returning international backers such as Fonds Stratégique des Transitions…









